In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole

American Journal of Obstetrics and Gynecology

Volumn 175, Issue 6, 1996, Pages 1626-1631

  Cooper C R , Jr ^a   McGinnis, M R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Fluconazole; susceptibility testing; terconazole; vulvovaginitis

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; TERCONAZOLE;

ARTICLE; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; DRUG SENSITIVITY; FEMALE GENITAL TRACT INFECTION; FUNGUS GROWTH; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; TORULOPSIS GLABRATA; VAGINA CANDIDIASIS; VULVOVAGINITIS; YEAST;

EID: 0030480820     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70116-3     Document Type: Article

References (25)

1. G Cauwenbergh H. Vanden Bossche Terconazole. Pharmacology of a new antimycotic agent J Reprod Med 34 1989 588 592
2. H Vanden Bossche P Marichal Mode of action of anti- Candida drugs: focus on terconazole and other ergosterol biosynthesis inhibitors Am J Obstet Gynecol 165 1991 1193 1199
3. SL Corson RR Kapikian R. Nehring Terconazole and miconazole cream for treating vulvovaginal candidiasis: a comparison J Reprod Med 36 1991 561 567
4. PL Doering TM. Santiago Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens DICP 24 1990 1078 1083
5. JL. Thomason Clinical evaluation of terconazole: United states experience J Reprod Med 34 1989 597 601
6. A Frega G Gallo F Di Renzi G Stolfi P. Stentella Persistent vulvovaginal candidiasis: systemic treatment with oral fluconazole Clin Exp Obstet Gynecol 21 1994 259 262
7. KW. Brammer Treatment of vaginal candidiasis with a single oral dose of fluconazole Eur J Clin Microbiol Infect Dis 7 1988 364 367
8. E Kutzer R Oittner S Leodolter KW. Brammer A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis: a report of a double-blind multicentre trial Eur J Obstet Gynecol Reprod Biol 29 1988 305 313
9. DJ Boken S Swindells MG Rinaldi Fluconazole-resistant Candida albicans Clin Infect Dis 17 1993 1018 1021
10. ML Cameron WA Schell S Bruch JA Bartlett HA Waskin JR Perfect Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1 Antimicrob Agents Chemother 37 1993 2449 2453
11. JA Sangeorzan SF Bradley X He LT Zarins GL Ridenour RN Tiballi Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance Am J Med 97 1994 339 346
12. P Chavanet J Lopez M Grappin A Bonnin M Duong A Waldner Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients AIDS 8 1994 945 950
13. JR Wingard WG Merz MG Rinaldi TR Johnson JE Karp R Saral Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole N Engl J Med 325 1991 1274 1277
14. S Cesaro F Rossetti G Perilongo L Rossi L Zanesco Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies Haematologica 78 1993 249 251
15. BJ Horowitz D Giaquinta S. Ito Evolving pathogens in vulvovaginal candidiasis: implications for patient care J Clin Pharmacol 32 1992 248 255
16. JH Rex MA Pfaller MG Rinaldi A Polak JN. Galgiani Antifungal susceptibility testing Clin Microbiol Rev 6 1993 367 381
17. N Troillet C Durussel J Bille MP Glauser JP Chave Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients Eur J Clin Microbiol Infect Dis 12 1993 911 915
18. National Committee for Clinical Laboratory Standards Reference method for broth dilution antifungal susceptibility testing of yeasts: proposed standard M27-T 1995 The Committee Villanova (PA)
19. MA Pfaller M Bale B Buschelman M Lancaster A Espinel-Ingroff JH Rex Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and 5-fluorocytosine J Clin Microbiol 33 1995 1104 1107
20. MA Pfaller B Dupont GS Kobayashi J Müller MG Rinaldi A Espinel-Ingroff Standardized susceptibility testing of fluconazole: an international collaborative study Antimicrob Agents Chemother 36 1992 1805 1809
21. A. Wardlaw Practical statistics for experimental biologists 1985 Wiley Chichester (UK)
22. ME Lynch JD. Sobel Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates J Med Vet Mycol 32 1994 267 274
23. ET Houang O Chappatte D Byrne PV MaCrae JE Thorpe Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasis Antimicrob Agents Chemother 34 1990 909 910
24. P. Dellenbach Penetration of fluconazole into vaginal tissues and secretions R Richardson Fluconazole and its role in vaginal candidiasis. 1989 Royal Society of Medicine Services London 19 22
25. SE Reef WC Levine MM McNeil S Fisher-Hoch SD Holmberg A Duerr Treatment options for vulvovaginal candidiasis, 1993 Clin Infect Dis 20 suppl 1 1995 S80 S90